Millie
your market intelligence analyst
Search Results
Edit Save
1,059 results
SynBioBeta 05/30/2020 06:30
With extended applications, Tapestri Designer, the only AI-powered cloud-based tool for single-cell panel designs, will improve drug development and CRISPR quality control studies South San Francisco, CALIF. – WEBWIRE – Thursday, May 28, 2020 Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced extended capabilities for Tapestri Designer, the first-ever automated, cloud-based tool […]. .
SynBioBeta 05/27/2020 06:36
Vancouver, Canada — May 26, 2020 — Renaissance BioScience Corp. (RBSC), a leading global bioengineering company, is pleased to announce that it will receive advisory services and a multi-year, non-repayable contribution of up to $493,625 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
SynBioBeta 05/23/2020 07:31
AbCellera will use its world-leading antibody drug discovery platform in a multi-year collaboration to identify antibodies against up to nine targets May 22, 2020 05:28 PM Eastern Daylight Time VANCOUVER, British Columbia–(BUSINESS WIRE)–AbCellera announced today that it has entered into a multi-year strategic research collaboration and license agreement with Eli Lilly and Company (Lilly) on the [...]. .
SynBioBeta 05/22/2020 07:04
Sales Significantly Exceeding Expectations EMERYVILLE, Calif., May 21, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of "Baby Cream to Powder" under its Pipette™ baby brand giving caring parents more choice [...]. .
SynBioBeta 05/22/2020 06:59
Atomwise democratizes access to its advanced AI technology with 15 research collaborations underway to enable academic researchers to discover novel therapies for this pandemic and those in the future. May 21, 2020 06:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Atomwise, the leader in using artificial intelligence (AI) for small molecule drug discovery, announced today it […]. .
SynBioBeta 05/22/2020 06:54
SHANGHAI and WORCESTER, Mass., May 18, 2020 /PRNewswire/ — WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced today the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in Worcester at The Reactory, a 46-acre master-planned biomanufacturing campus.
SynBioBeta 05/21/2020 08:58
Sherlock Innovation Lab to Stimulate New England Economy by Creating New Jobs for Industry and Academic Experts Impacted by COVID-19 Pandemic Funding to Accelerate Development of INSPECTR™ Rapid Diagnostic Platform to Improve Testing in At-home and Low-resource Settings May 21, 2020 08:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sherlock Biosciences, an Engineering Biology company dedicated to [...]. .
SynBioBeta 05/21/2020 07:57
CAMBRIDGE, Mass., May 21, 2020 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today announced the termination of its collaboration with AbbVie, a global, research-based biopharmaceutical company, for the development of Synthetic Biotic medicines for the potential treatment of inflammatory bowel disease (IBD).
SynBioBeta 05/20/2020 09:12
Acquisition enables full integration of R&D and production for ongoing and future xenotransplant programs Contract production partner will become a wholly-owned subsidiary of eGenesis CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) — eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs, tissues, and cells to address [...]. .
SynBioBeta 05/20/2020 09:02
Company also Applying its High-throughput RNA-amplicon Sequencing Platform to Accelerate COVID-19 Testing Efforts May 20, 2020 08:30 AM Eastern Daylight Time EMERYVILLE, Calif.–(BUSINESS WIRE)–Octant, Inc., a synthetic biology drug discovery company designing small molecule, multi-target drug leads for multifactorial diseases announced that it has raised $30 million in a Series A financing led by venture [...]. .
SynBioBeta 05/20/2020 06:30
In 2013, a mysterious new flu virus hit the world. It was the H7N9 strain of bird flu, and by the time it infected 120 and killed 23, researchers still didn’t know how it was transmitted or how to stop it. As the virus arrived in the dense Chinese province of Hunan, health officials began […]. .
SynBioBeta 05/19/2020 05:52
May 18, 2020 06:49 PM Eastern Daylight Time – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Centivax Inc, the therapeutics spin-out of Contract Research Organization Distributed Bio Inc, announced a significant advance in their mission to develop an optimized antibody therapeutic to treat COVID-19.
SynBioBeta 05/17/2020 04:32
As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.
SynBioBeta 05/17/2020 03:26
Enzymicals AG, a German enterprise focusing on industrial biocatalysis and Syngulon, a Belgian synthetic biology company developing original genetic technologies using bacteriocins, announce a non-exclusive license agreement which provides Enzymicals access to Syngulon’s patented selection technology.

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications